Puma Biotechnology (PBYI) Capital Expenditures (QoQ) (2011 - 2025)
Puma Biotechnology (PBYI) Capital Expenditures (QoQ) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Puma Biotechnology |
384.39 Mn |
282.84 Mn |
34.39 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-492.31% |
| Sep 30, 2025 |
30.00% |
| Jun 30, 2025 |
-67.21% |
| Mar 31, 2025 |
405.00% |
| Dec 31, 2024 |
-300.00% |
| Sep 30, 2024 |
0.00% |
| Dec 31, 2023 |
-186.25% |
| Dec 31, 2022 |
-200.00% |
| Dec 31, 2020 |
109.09% |
| Sep 30, 2020 |
1,200.00% |
| Jun 30, 2020 |
-107.69% |
| Dec 31, 2018 |
-224.59% |
| Sep 30, 2018 |
90.63% |
| Jun 30, 2018 |
88.24% |
| Mar 31, 2018 |
132.82% |
| Dec 31, 2017 |
-296.21% |
| Sep 30, 2017 |
340.00% |
| Jun 30, 2017 |
-75.81% |
| Mar 31, 2017 |
-77.74% |
| Dec 31, 2016 |
-24.01% |
